Loading insider details...
Beta
Latest Form 4 (Oct 3, 2026): Tax Withholding of 40,309 ROIV shares, $1.47M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 3, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 40,309 | $1.47M |
| Jul 2, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 40,310 | $1.43M |
| Apr 9, 2026 | Immunovant, Inc. (IMVT) | Grant/Award | 174,189 | n/a |
| Apr 2, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 160,035 | $4.43M |
| Feb 24, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 1,400,000 | $5.39M |
| Dec 30, 2025 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 175,380 | $3.94M |
| Aug 2, 2025 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 1,836,547 | n/a |
| Apr 3, 2025 | Immunovant, Inc. (IMVT) | Grant/Award | 199,365 | n/a |
| May 24, 2024 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 67,000 | n/a |
| Apr 4, 2024 | Immunovant, Inc. (IMVT) | Grant/Award | 120,400 | n/a |